Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer thanks to real time in vivo microscopic visualization. The Company s flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. More than systems around the world and investigators have generated more than publications on clinical applications of endomicroscopy.
Quote | Mauna Kea Techs Nom Cate (OTCMKTS:MKEAF)
Last: | $0.37 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.37 |
High: | $0 |
Low: | $0 |
Volume: | 10,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Mauna Kea Techs Nom Cate (OTCMKTS:MKEAF)
Mauna Kea Technologies (OTCPK:MKEAF) (OTCPK:MKEAY) said it received a U.S. FDA 510(k) clearance for the use of Cellvizio 100 Series platform with a molecular imaging agent, the first of its kind, for real-time in vivo visualization during endoscopic, laparoscopic, and needle-based procedures....
Mauna Kea Technologies ADR (MKEAY): Q2 Revenue of €1.7M (+183.3% Y/Y)Assuming the global capital equipment recovery continues, the Company continues to expect to increase sales in the range of 25% to 30% year-over-year for the twelve months ending December 31, 2021 vs. consensus g...
Message Board Posts | Mauna Kea Techs Nom Cate (OTCMKTS:MKEAF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Mauna Kea (MKEAF) Headlines Mauna Kea Technologies Receives 510(k) Regulatory | Stock_Tracker | investorshangout | 03/10/2014 6:13:45 PM |
chartguy89: MKEAF 12.4886 Stock Charts $MKEAF 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 7:57:14 PM |
chartguy89: MKEAF Stock Charts Last: -3.9441 Thursday, February 27, 2014 at 11:57:53 PM $MKEAF | chartguy89 | investorshangout | 02/28/2014 4:58:04 AM |